LifeMD, Inc. (NASDAQ:LFMD) Shares Could Be 50% Below Their Intrinsic Value Estimate

Yahoo FinanceJan 16 05:06 ET

LifeMD Is Maintained at Overweight by Keybanc

Dow JonesJan 8 15:46 ET · Ratings

KeyBanc Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $7

Moomoo NewsJan 8 07:34 ET · Ratings

KeyBanc Cuts Price Target on LifeMD to $7.50 From $10, Keeps Overweight Rating

MT NewswiresJan 8 07:26 ET · Ratings

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND For GLP-1 Users & Those Looking for Help to Keep Weight Off

BusinesswireJan 7 08:30 ET

Insider Sale: Chief Executive Officer of $LFMD (LFMD) Sells 25,000 Shares

Quiver QuantitativeJan 6 17:46 ET